Ligand Pharmaceuticals
LGND
LGND
165 hedge funds and large institutions have $1.09B invested in Ligand Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 61 increasing their positions, 38 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
165
Holders Change
+33
Holders Change %
+25%
% of All Funds
4.79%
Holding in Top 10
8
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+300%
% of All Funds
0.23%
New
53
Increased
61
Reduced
38
Closed
20
Calls
$25.8M
Puts
$4.41M
Net Calls
+$21.4M
Net Calls Change
+$23.5M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
176
JPMorgan Chase & Co
New York
| – | -$476K | -17,603 | Closed |
|
|
TMC
177
Trellus Management Company
Delray Beach,
Florida
| – | -$415K | -15,389 | Closed |
|
|
HCM
178
Highbridge Capital Management
New York
| – | -$356K | -13,185 | Closed |
|
179
Westfield Capital Management
Boston,
Massachusetts
| – | -$294K | -10,900 | Closed |
|
180
SG Americas Securities
New York
| – | -$130K | -4,803 | Closed |
|
181
Group One Trading
Chicago,
Illinois
| – | -$117K | -4,351 | Closed |
|
|
ICRM
182
Insight Capital Research & Management
Walnut Creek,
California
| – | -$120K | -3,709 | Closed |
|
183
First Manhattan
New York
| – | -$63K | -2,348 | Closed |
|
|
FA
184
Financial Advantage
Columbia,
Maryland
| – | -$6K | -240 | Closed |
|
|
TRCT
185
Tower Research Capital (TRC)
New York
| – | -$1K | -43 | Closed |
|
|
ST
186
SpiderRock Trading
Chicago,
Illinois
| – | -$3K | – | – |
|